Xenetic Biosciences Inc
About
Xenetic Biosciences Inc (NASDAQ:XBIO) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 22 2026
Xenetic Biosciences, Inc. Announces Abstract Acceptance for Presentation at the 2026 ASCO Annual Meeting
Mar 13 2026
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
Dec 11 2025
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
Nov 19 2025
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
Nov 13 2025
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
Financials
Revenue
$2.98 M
Market Cap
$6.9 M
EPS
-1.58